MCP
NVO

Martin Capital Partners’s Novo Nordisk NVO Stock Holding History

Martin Capital Partners’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.77M Buy
120,258
+3,078
+3% +$132K 2.12% 20
2026
Q1 		$4.31M Buy
117,180
+2,189
+2% +$104K 1.6% 35
2025
Q4 		$5.85M Sell
114,991
-2,586
-2% -$132K 2.2% 19
2025
Q3 		$6.52M Buy
117,577
+41,129
+54% +$2.41M 2.53% 18
2025
Q2 		$5.28M Buy
76,448
+55,298
+261% +$3.76M 2.07% 24
2025
Q1 		$1.47M Buy
+21,150
New +$1.75M 1.76% 31

Other funds holding NVO

SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
QI
QV Investors Calgary, Alberta, Canada $1.3B AUM 31.14% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
OFA
Oak Family Advisors Chicago, Illinois $391M AUM 26.35% 1-Year Est. Return
PM
Penbrook Management New York $157M AUM 46.57% 1-Year Est. Return
PFS
Prospera Financial Services Dallas, Texas $6.89B AUM 37.41% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Martin Capital Partners's NVO Position: Q2 2026 in Review

Martin Capital Partners increased its Novo Nordisk (NVO) stake by 2.6% in Q2 2026, buying an estimated $132K and bringing the position to 120,258 shares worth $5.77M. The position accounts for 2.12% of the portfolio, ranked #20.

Martin Capital Partners first reported a position in NVO in Q1 2025 and has held it in 6 quarters since. The position peaked at $6.52M in Q3 2025. 344 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Martin Capital Partners held 120,258 shares of Novo Nordisk worth $5.77M as of Q2 2026.
  • Martin Capital Partners bought 3,078 Novo Nordisk shares in Q2 2026, an estimated $132K.
  • Novo Nordisk made up 2.12% of Martin Capital Partners's portfolio in Q2 2026, its #20 holding.
  • Martin Capital Partners first reported a position in Novo Nordisk in Q1 2025 and has held it in 6 quarters since.
  • Martin Capital Partners's Novo Nordisk position peaked at $6.52M in Q3 2025.
  • 344 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Martin Capital Partners's 13F filing for Q2 2026, filed 7 Jul 2026.